CB2R induces a protective response for epileptic seizure via the PI3K 110α‑AKT signaling pathway

  • Authors:
    • Qingjun Cao
    • Xueyan Liu
    • Fenghua Yang
    • Hua Wang
  • View Affiliations

  • Published online on: September 24, 2018     https://doi.org/10.3892/etm.2018.6788
  • Pages: 4784-4790
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Epilepsy is a chronic brain disease caused by abnormal discharging in the brain, which induces momentary brain dysfunction. Cannabinoid 2 receptor (CB2R) is expressed in central nervous system (CNS) and serves an important role in the pathogenesis of CNS diseases. The aim of the present study was to explore the effects of CB2R activation on phosphoinositide 3‑kinase (PI3K) 110α‑protein kinase B (AKT) signaling in an astrocyte model of epilepsy. Rat CTX TNA2 astrocytes were treated with Mg free solution to establish a cell model of epilepsy and were subsequently treated with a CB2R agonist (JWH133) and antagonist (AM630). Cell cycle analysis revealed that treatment using Mg free solution inhibited cell cycle transition. JWH133 facilitated cell cycle progression while AM630 inhibited it. Western blotting results demonstrated that treatment with Mg free solution downregulated the expression of cyclin D1, cyclin E, phosphorylated Retinoblastoma (p‑Rb), B‑cell lymphoma 2 (Bcl‑2), PI3K 110α, p‑AKT and p‑mammalian target of rapamycin, whereas JWH133 treatment upregulated these proteins. AM630 ameliorated the JWH133‑induced upregulation of these proteins. To confirm the involvement of AKT signaling, the AKT inhibitor wortmannin was used. The results revealed that wortmannin inhibited the effect of JWH133 on p‑AKT, cyclin D1, p‑Rb and Bcl‑2 expression. In addition, the effects of JWH133 and AM630 on PI3K 110α‑AKT signaling were verified using a rat model of epilepsy. In conclusion, the present study demonstrates that CB2R activation induces astrocyte proliferation and survival via activation of the PI3K 110α‑AKT signaling pathway.
View Figures
View References

Related Articles

Journal Cover

December-2018
Volume 16 Issue 6

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Cao Q, Liu X, Yang F and Wang H: CB2R induces a protective response for epileptic seizure via the PI3K 110α‑AKT signaling pathway. Exp Ther Med 16: 4784-4790, 2018
APA
Cao, Q., Liu, X., Yang, F., & Wang, H. (2018). CB2R induces a protective response for epileptic seizure via the PI3K 110α‑AKT signaling pathway. Experimental and Therapeutic Medicine, 16, 4784-4790. https://doi.org/10.3892/etm.2018.6788
MLA
Cao, Q., Liu, X., Yang, F., Wang, H."CB2R induces a protective response for epileptic seizure via the PI3K 110α‑AKT signaling pathway". Experimental and Therapeutic Medicine 16.6 (2018): 4784-4790.
Chicago
Cao, Q., Liu, X., Yang, F., Wang, H."CB2R induces a protective response for epileptic seizure via the PI3K 110α‑AKT signaling pathway". Experimental and Therapeutic Medicine 16, no. 6 (2018): 4784-4790. https://doi.org/10.3892/etm.2018.6788